however, the precise role of this transcription factor in regulating NK cell function remains unknown. Here, we show that cell-intrinsic IRF8 was required for NK-cell-mediated protection against mouse cytomegalovirus infection. During viral exposure, NK cells upregulated IRF8 through interleukin-12 (IL-12) signaling and the transcription factor STAT4, which promoted epigenetic remodeling of the Irf8 locus. Moreover, IRF8 facilitated the proliferative burst of virus-specific NK cells by promoting expression of cell-cycle genes and directly controlling Zbtb32, a master regulator of virus-driven NK cell proliferation. These findings identify the function and cell-type-specific regulation of IRF8 in NK-cellmediated antiviral immunity and provide a mechanistic understanding of viral susceptibility in patients with IRF8 mutations.
In Brief
The link between human IRF8 mutations and immunodeficiency is poorly understood. Adams et al (Lanier, 2005) . Their germline-encoded receptor repertoire and status as poised effectors classically position NK cells as cells of the innate immune system. However, more recent evidence suggests that NK cells possess features of adaptive immunity, including their derivation, requirements for homeostatic maintenance, and acquisition of functional competence . Recent studies have demonstrated that NK cells undergo a robust burst of clonal proliferation during mouse cytomegalovirus (MCMV) infection to promote viral clearance (Daniels et al., 2001; Dokun et al., 2001; Sun et al., 2009 ) and establish a long-lived memory population with enhanced protective function against MCMV reinfection (Sun et al., 2009 ); these functions were thought to be limited solely to T and B cells of the adaptive immune system.
During MCMV infection, NK cells mediate this ''adaptive'' antiviral response by binding the viral glycoprotein m157 on infected cells with the DAP12-dependent activating receptor Ly49H (Arase et al., 2002; Daniels et al., 2001; Dokun et al., 2001; Sun et al., 2009 ). In addition to detecting viral ligands, these adaptive NK cell responses critically require proinflammatory cytokines, particularly interleukin-12 (IL-12), IL-18, and type I interferons, which play differential roles in supporting NK cell proliferation and survival during expansion and imprinting the effector-tomemory NK cell transition (Madera et al., 2016; Madera and Sun, 2015; Sun et al., 2012) . Nevertheless, the transcriptional regulators that NK cells employ to integrate these signals, as well as the transcriptional programs they drive to generate antiviral responses, are only beginning to be elucidated.
The interferon regulatory factor (IRF) family of transcription factors consists of nine members in mammals with differential dependencies on type I and type II interferon signaling and pleiotropic functions both within and outside the immune system (Tamura et al., 2008) . Our current understanding of the requirement for IRF family members in mouse NK cell development and function is limited to IRF1 and IRF2. NK cell development is impaired in germline Irf1 À/À mice (Duncan et al., 1996; Ogasawara et al., 1998; Taki et al., 1997) ; however, this was demonstrated to be secondary to IRF1-dependent IL-15 production by radiation-resistant bone marrow stromal cells that support NK cell development (Ogasawara et al., 1998) . In contrast, IRF2 is thought to be required in a cell-intrinsic manner to support the survival of mature peripheral NK cells (Lohoff et al., 2000; Taki et al., 2005) . More recently, a clinical study identified compound-heterozygous or homozygous IRF8 mutations that segregated with severe, and in some cases fatal, viral susceptibility in three unrelated families (Mace et al., 2017) . These patients possessed a greatly diminished number of mature NK cells and reduced NK cell cytolytic function, suggesting a role for IRF8 in NK cell development and function. However, the direct in vivo function of IRF8 in NK cells has not been established. Expression of IRF8 (also known as ICSBP) is restricted to the immune system, and a growing number of studies have revealed the critical and divergent roles that IRF8 plays in the transcriptional regulation of hematopoiesis and peripheral immune responses, including monocyte and dendritic cell (DC) lineage commitment (Holtschke et al., 1996; Schiavoni et al., 2002; Tamura et al., 2000) , B cell development (Lu et al., 2003) , germinal center reactions (Lee et al., 2006; Xu et al., 2015) , T helper 1 (Th1) cell differentiation (Giese et al., 1997; Scharton-Kersten et al., 1997) , and thymic selection (Herzig et al., 2017) . Given its prominent role in lymphocyte biology and its frequent mutation in familial cases of NK cell deficiency and viral susceptibility, we hypothesized that IRF8 might act as an essential regulator of NK cell antiviral responses.
In this article, we show that the transcription factor IRF8 played a critical and non-redundant role in facilitating the proliferative burst of virus-specific NK cells during acute viral infection but was dispensable for their development. We used conditional Irf8 ablation to demonstrate that IRF8 was required in a cellintrinsic manner for host protection against lethal viral challenge, consistent with the induction of IRF8 during early NK cell activation. We found that the IL-12 and STAT4 signaling axis promoted IRF8 upregulation, which drove the proliferation of antigenspecific NK cells by activating a transcriptional program that promoted cell-cycle progression and expression of the proproliferative transcription factor Zbtb32. These findings attribute a function and regulation for IRF8 in NK-cell-mediated host immunity.
RESULTS
NK Cells Require IRF8 for Antiviral Immunity NK cells play an essential, dominant role in control of MCMV and human cytomegalovirus (HCMV) infection in mice and humans, respectively (Biron et al., 1989; Bukowski et al., 1985; Etzioni et al., 2005) . To determine whether IRF8 is required for host antiviral immunity, we first challenged wild-type (WT) and Irf8 Figure S1 .
Irf8
À/À mice rapidly succumbed to MCMV infection as a result of elevated viral burden ( Figures 1A and 1B) . Loss of IRF8-dependent CD8a + DCs in Irf8
mice impairs IL-12 production (Giese et al., 1997; Scharton-Kersten et al., 1997) , which is required for priming NK cells (Sun et al., 2012) . Therefore, to investigate whether NK cells require IRF8 in a cell-intrinsic fashion for MCMV control, we began by generating a genetic mouse model with conditional deletion of Irf8 exon 2 specifically in NK cells (Nkp46 iCre/+ Irf8 fl/fl , herein designated as NK-Irf8 À/À ) ( Figure S1A ). NK cell numbers, frequency, maturation, and receptor repertoire were unaffected by the loss of IRF8 ( Figures S1B-S1E Figure 2A ) and was more expressed and upregulated than other IRF family members (Figure 2B) . During MCMV infection, IRF8 was upregulated during early NK cell activation at both the transcript and protein levels ( Figures 2C and 2D ). However, maintenance of maximal IRF8 expression was transient, such that both transcript and protein returned nearly to baseline within 1 week and at memory time points ( Figures 2C and 2D ), suggesting that IRF8 functions in the early programming of antiviral NK cell responses.
IRF8 was first described to be induced in lymphocytes and macrophages by interferon-g (IFN-g) (Driggers et al., 1990) ; however, IRF8 upregulation in NK cells during MCMV infection was not dependent upon IFN-g ( Figure 3A ). Because peak IRF8 expression was observed at early time points in vivo, we hypothesized that when inflammation is maximal (Biron and Tarrio, 2015) , proinflammatory cytokines such as IL-12, IL-18, or type I interferons might instead regulate IRF8 induction in activated NK cells. We generated mixed-bone-marrow chimeric mice harboring both WT cells and cells deficient in receptors for various proinflammatory cytokines (IL-12, IL-18, or type I interferons) and downstream STAT signaling molecules (STAT1 or STAT4) and challenged them with MCMV ( Figure 3B ). Compared with WT NK cells, NK cells that were unresponsive to IL-12 signaling (through either the absence of the IL-12 receptor or its downstream effector STAT4) had an impaired ability to maximally upregulate IRF8 after infection ( Figure 3C ). In contrast, IRF8 upregulation in Ifnar1
, and Stat1 À/À NK cells remained unaffected ( Figure 3C ). Collectively, these data suggest an NK-cell-specific mechanism of IRF8 regulation by IL-12 and STAT4. However, IRF8 induction in vivo was not fully abrogated in the absence of IL-12 and STAT4 signaling, suggesting a role for other factors. Indeed, Ly49H signaling in NK cells synergized with IL-12 to drive maximal IRF8 induction ( Figure 3C ), consistent with an analogous report that T cell receptor (TCR) signaling contributes to IRF8 expression in antigen-specific CD8 + T cells (Miyagawa et al., 2012) . Furthermore, ex vivo stimulation with IL-12 or common-g-chain-dependent cytokines (IL-2 and IL-15) was also sufficient to promote IRF8 upregulation in NK cells ( Figure S2A ). Given the dependence of NK cells on common-g-chain-dependent cytokines for their survival in the periphery (Jamieson et al., 2004; Prlic et al., 2003; Ranson et al., 2003) , the contribution of common-g-chain-dependent cytokines in IRF8 induction during MCMV infection in vivo cannot be assessed in the same manner as for IL-12. Nevertheless, signaling through these two pathways (Ly49H and common-g-chain-dependent receptors) most likely synergizes with IL-12 signaling to regulate IRF8 expression in NK cells during MCMV infection. Groups with a ratio < 1 were compared against a hypothetical value of 1 with a one-sample t test. Data are presented as the mean ± SEM. *p < 0.05, ****p < 0.0001. (D) Sorted splenic NK cells were stimulated with IL-12 and IL-18 for 16 hr or unstimulated and then subjected to STAT4 ChIP-seq. STAT4 ChIP-seq reads mapping to the Irf8 locus are shown in black (top and middle). Data are representative of three independent experiments. Ly49H + NK cells were sorted from the spleen at p.i. day 2 and then subjected to ATAC-seq. ATAC-seq reads mapping to the Irf8 locus are shown in green (bottom). Data are representative of three independent experiments each with two to three replicates. Irf8 exons are shown as gray boxes, and the black arrow denotes the origin and directionality of transcription.
(E) NK cells sorted from the spleens of WT or Stat4 À/À mice were stimulated with IL-12 and IL-18 for 30 min or unstimulated and then subjected to H3K4me3
ChIP-seq. H3K4me3 signal from the Irf8 locus is plotted as normalized fragment counts binned at 50 bp across a 20-kb window centered on the transcriptional start site (TSS). Data are representative of two independent experiments. See also Figure S2 .
In agreement with the necessary role for IL-12 and STAT4 signaling in IRF8 induction, genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) showed that STAT4 occupied the Irf8 promoter ( Figure 3D ), and Irf8 was among the top ten STAT4-bound transcription factor loci in activated NK cells ( Figure S2B ). An assay for transposase-accessible chromatin with high throughput sequencing (ATAC-seq) revealed that STAT4 binding co-localized with a region of increased accessibility in the Irf8 promoter in Ly49H + NK cells at p.i. day 2 ( Figures   3D and S2C ). Furthermore, we detected STAT4-dependent trimethylation of histone H3 at lysine 4 (H3K4me3, which marks transcriptionally active promoters) at the Irf8 locus in NK cells stimulated with proinflammatory cytokines ( Figure 3E ). Together, these data suggest that STAT4 could actively remodel the epigenetic landscape to promote IRF8 induction in activated NK cells. Given the requirement for IL-12 and STAT4 for the clonal expansion of effector NK cells and the generation of memory NK cells (Sun et al., 2012 ), IRF8 appears to represent a key effector molecule that drives a transcriptional program supporting antiviral NK cell responses downstream of the IL-12 and STAT4 axis.
NK Cells Require IRF8 for Virus-Driven Expansion MCMV-induced NK cell activation results in the rapid production and release of cytolytic molecules (e.g., perforin and granzyme B) and proinflammatory cytokines (e.g., IFN-g), which lead to lysis of infected cells and establishment of an antiviral state, as well as antigen-specific clonal proliferation of the Ly49H + NK cell subset . Given the poor protective capacity of NK-Irf8 À/À NK cells, we sought to delineate which of these effector functions is regulated by IRF8. WT and NK-Irf8
NK cells demonstrated comparable proinflammatory-cytokinedependent activation and IFN-g production during MCMV infection in vivo ( Figures S3A and S3B ), as well as after cytokine or phorbol 12-myristate 13-acetate (PMA) and ionomycin stimulation in vitro ( Figure S3C ). Compared with WT cells, NK-Irf8
NK cells showed similarly unaffected granzyme B production ( Figure S3B ), resulting in normal in vivo elimination of m157-expressing target cells ( Figure S3D ). To test the role of IRF8 in MCMV-driven NK cell expansion, we adoptively co-transferred WT and NK-Irf8 À/À NK cells at equal numbers into Ly49H-deficient (Klra8 À/À ) recipient mice, infected the recipients with MCMV, and tracked the transferred effector Ly49H + NK cell response in the recipients ( Figure 4A ). In contrast to WT NK cells, which expanded robustly and reached peak numbers at p.i. day 7, NK-Irf8 À/À NK cells were significantly reduced at this time point ( Figure 4B ). However, NK cells from Cre-negative littermate control mice expanded comparably to WT cells ( Figure S3E ). The defective expansion of NK-Irf8 À/À NK cells was observed as early as p.i. day 3 and was consistent across various organs ( Figure 4C ), excluding impaired trafficking as an explanation for the observed phenotype. However, despite the poor expansion, IRF8 deficiency Groups were compared with an unpaired, two-tailed Student's t test (B) or against a hypothetical value of 50 with a one-sample t test (C-E). Data are presented as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0. 4D ). Although reduced in number, IRF8-deficient memory NK cells were functional upon re-stimulation ( Figure S3H ). To determine whether IRF8 is required for adaptive NK cell responses against other viruses, we infected mice with recombinant vesicular stomatitis virus engineered to express the MCMV gene m157 (VSV-m157). During VSV-m157 infection, NK-Irf8
NK cells were similarly outcompeted by WT NK cells and ultimately formed a smaller pool of memory NK cells ( Figure 4E ), suggesting that the requirement for IRF8 in antigen-specific NK cell expansion is not limited to MCMV infection. However, IRF8 was not required for hapten-specific NK-cell-mediated contact hypersensitivity responses ( Figure S4 ), suggesting that IRF8 plays a critical role only during infectious priming, but not non-infectious priming, of adaptive NK cell responses.
To address whether IRF8 directly maintains virus-specific memory NK cell numbers, we generated a mouse model in which the floxed exon 2 of Irf8 could be excised by a tamoxifen-inducible Cre cassette driven by the ubiquitin promoter (Ubc
Cre-ERT2

Irf8
fl/fl ). In our adoptive co-transfer system, recipient mice were treated with either tamoxifen or oil just before the contraction phase (p.i. days 7-9), resulting in successful deletion of Irf8 in tamoxifen-treated, but not oil-treated, Ubc
Cre-ERT2
fl/fl NK cells ( Figure S3I ). Inducible deletion of Irf8 after NK cell expansion did not affect the formation of the memory NK cell pool, given that Ubc Cre-ERT2 Irf8 fl/fl memory NK cells were found at similar proportions in the blood of tamoxifen-and oil-treated mice ( Figure S3I ). Thus, IRF8 is essential in driving the expansion, but not the memory maintenance, of virus-specific NK cells. NK cells also undergo homeostatic proliferation in a lymphopenic environment, thought to be driven by the availability of common-g-chain-dependent cytokines . NKIrf8 À/À NK cells were found to be defective in homeostatic proliferation after adoptive transfer into Rag2
lack both innate and adaptive lymphocytes ( Figure S5A ). Consistent with common-g-chain-dependent IRF8 expression in CD8 + T cells (Miyagawa et al., 2012) and human NK cells (Mace et al., 2017) , IRF8 abundance trended upward in lymphopenia-driven NK cells ( Figure S5B ). These findings collectively indicate that IRF8 is specifically needed to support the robust expansion of mature NK cell numbers during infection and homeostatic proliferation, whereas redundant mechanisms exist for NK cell development and homeostatic maintenance, which necessitate modest cell turnover.
IRF8 Promotes Proliferation through Direct Regulation of Zbtb32
To investigate IRF8-regulated pathways that might promote NK cell expansion, we performed comparative transcriptome analysis by RNA-seq on purified WT and NK-Irf8 À/À NK cells derived from MCMV-infected and -uninfected mixed-bone-marrow chimeric mice ( Figure 5A ). Consistent with the reported ability of IRF8 to act as a transcriptional activator or repressor depending on its binding partner (Tamura et al., 2015) , 323 transcripts were downregulated, and 379 transcripts were upregulated in NK-Irf8 À/À NK cells compared with WT NK cells at p.i. day 4 (Table S1 ). Classification of differentially expressed genes into PANTHER pathways revealed a transcriptional program consistent with dysregulated cell-cycle control, DNA replication, and metabolism in NK-Irf8 À/À NK cells ( Figure S6A ). Because these gene sets trended toward being comparatively enriched in WT NK cells (
Figure 5B Figure 5C ).
In contrast, NK-Irf8 À/À NK cells exhibited normal expression of the pro-survival protein Bcl-2 and no evidence of enhanced caspase activation during MCMV-driven expansion ( Figures S6B  and S6C ). Collectively, these data indicate that IRF8 is essential for inducing a broad transcriptional program that primarily serves to promote MCMV-driven NK cell proliferation. We next sought to pinpoint key IRF8 transcriptional targets that promote NK cell proliferation during infection in vivo. Given that baseline transcriptional differences exist between WT and NK-Irf8 À/À NK cells ( Figure 5A ) yet there is no NK cell developmental phenotype in the absence of IRF8 ( Figure S1 ), we reasoned that infection-specific transcriptional differences would best explain the impaired proliferation of NK-Irf8 À/À NK cells. Our RNA-seq analysis identified a subset of genes that were differentially upregulated or downregulated in NK-Irf8
NK cells in an infection-specific manner ( Figures 6A, 6B , and S6D). One such gene was Zbtb32, which was more highly induced in WT than in NK-Irf8 À/À NK cells during MCMV infection ( Figures 6A-6C ). Zbtb32 is a BTB-ZF (broad complex, tramtrack, bric-á -brac, and zinc finger) transcription factor previously reported to be essential for the proliferative burst of MCMV-specific NK cells (Beaulieu et al., 2014) . In silico analysis identified multiple IRF8 binding sites that fall in moderate to highly conserved non-coding sequence (CNS) regions within the Zbtb32 locus ( Figure 6D ), and some of these are bound by IRF8 in other immune cells (Langlais et al., 2016; Marquis et al., 2011; Shin et al., 2011) . Moreover, IRF8 ChIP followed by qPCR revealed enrichment of Zbtb32 promoter DNA (compared with a gene desert following immunoprecipitation with a-IRF8 antibody), confirming that Zbtb32 is a direct target of IRF8-mediated transcriptional activation ( Figure 6E ). However, during MCMV infection, IRF8 induction in NK cells was found to be independent of Zbtb32 ( Figure S6E ). Given that the Zbtb32 locus is bound to IRF8 ( Figure 6E ) and that Zbtb32 expression is dependent on IRF8 ( Figures 6A-6C) , we thus propose a model wherein IRF8 functions upstream of Zbtb32 to drive antiviral NK cell proliferation.
DISCUSSION
A growing body of literature supports the paradigm that NK cells in mice, primates, and humans undergo antigen-specific responses to viral pathogens (Adams et al., 2016) . Adaptive NK cell responses include the prolific expansion and memory formation of virus-specific NK cell subsets (Sun et al., 2009 ), yet the transcriptional control of these processes is poorly understood. Here, we have revealed that the transcription factor IRF8 is dynamically regulated in antigen-specific NK cells during viral infection and is essential for NK-cell-mediated immunity against MCMV. In contrast to its canonical regulation throughout the immune system by IFN-g (Driggers et al., 1990) mice has been demonstrated to impair IL-12 production in a variety of pathogen models (Giese et al., 1997; Scharton-Kersten et al., 1997) . During early MCMV infection, IRF8-dependent cDC1s are the major producer of IL-12 , and IL-12 signaling is critical for programming adaptive NK cell responses to MCMV infection (Sun et al., 2012) . Thus, the striking mortality of Irf8 À/À mice during MCMV infection is most likely a combination of both cell-extrinsic (impaired NK cell priming due to low systemic IL-12 in the absence of cDC1s) and cellintrinsic (impaired IRF8-dependent NK cell proliferative burst) functions of IRF8. During MCMV infection, we observed that IRF8 drives a transcriptional program consistent with cell-cycle progression. This program supports NK cell clonal proliferation such that NK cells can mount a maximal effector response. Our data suggest that the output of the IRF8 transcriptional program is most likely mediated in part by IRF8's direct binding to the Zbtb32 locus to promote expression of Zbtb32, a pro-proliferative transcription factor previously reported to be essential for controlling the proliferative burst of virus-specific NK cells (Beaulieu et al., 2014) , thus elucidating a previously uncharacterized relationship between these two transcription factors. Given its function, Zbtb32 is tightly regulated by NK cells during both homeostasis and MCMV infection. Naive NK cells do not express Zbtb32, but NK cells transiently upregulate Zbtb32 nearly 100-fold during MCMV infection in a manner similarly dependent on IL-12 signaling (Beaulieu et al., 2014) . Maximal Zbtb32 induction is Figure 4A , except that NK cells were labeled with CTV before adoptive co-transfer. Left: representative histograms of CTV in splenic and hepatic WT and NK-Irf8 À/À Ly49H + NK cells at p.i. day 3. Right: quantification of Ly49H + NK cells that divided at least once. Data are representative of two independent experiments each with four mice. Groups were compared with an unpaired, two-tailed Student's t test. Data are presented as the mean ± SEM. ***p < 0.001, ****p < 0.0001. See also Figure S6 and Table S1 .
critical given that Zbtb32 hemizygosity is insufficient to drive NK cell expansion during viral infection (Beaulieu et al., 2014) . Because STAT4 itself also directly regulates Zbtb32 expression, this could explain why only incomplete, yet not abrogated, Zbtb32 upregulation was observed in the absence of IRF8. Because additional transcription factors might also regulate Zbtb32 transcription (either individually or in concert with STAT4 and IRF8), it will be important to determine the complete mechanisms that ensure a robust IL-12 and STAT4 effector program within activated NK cells. Despite the requirement for IRF8 in NK cell antiviral immunity, we observed no impact of IRF8 deficiency on NK cell development. This observation appears inconsistent with findings in patients who, across three unrelated families, have biallelic IRF8 mutations and exhibit impaired terminal maturation and diminished overall numbers of NK cells (Mace et al., 2017) . Perhaps this discrepancy can be ascribed to our use of a specific deletion of Irf8 in NK cells of transgenic mice, whereas NK cells in these patients developed in the presence of hematopoietic and stromal cells that also bear the IRF8 mutations. Despite carrying biallelic IRF8 mutations, the NK-cell-deficient patient had normal amounts of IRF8, which translocated normally to the nucleus and demonstrated unaffected transcriptional activity dependent on PU.1 and IRF1, two of its canonical binding partners (Mace et al., 2017) . Thus, the mutant IRF8 in humans could have an altered function within the NK cell population rather than represent a nonfunctional protein or the ablated gene we investigated in mice. WT NK- (hg19) genomes (UCSC Genome Browser). Conserved non-coding sequences (CNSs) are defined as having >70% homology over >100 bp. The location relative to the TSS and the sequence of the putative IRF8 motif are listed for each putative IRF8 binding site. (E) Sorted splenic NK cells were stimulated with IL-2, IL-12, IL-15, and IL-18 for 16 hr. IRF8-DNA complexes were immunoprecipitated and then subjected to qPCR for amplification across a putative IRF8 binding site 2,975 bp upstream of the Zbtb32 promoter. A gene desert $50 kb upstream of the Foxp3 locus served as a negative control for IRF8 binding. Data are representative of two independent experiments. Samples were compared with an unpaired, two-tailed Student's t test. Data are presented as the mean ± SEM. *p < 0.05. See also Figure S6 and Table S1 .
In our study, we delineated a dichotomous requirement for IRF8 in NK cells, and it appears to be dependent on the degree of cell turnover given that IRF8 was required for MCMV-and lymphopenia-driven proliferation but dispensable for development and homeostatic maintenance. However, it remains unclear how IRF8 is targeted for transcriptional activity during different cellular states. Recent studies have found that dynamic epigenetic changes accompany CD8 + T cell differentiation during bacterial and viral infection and can modulate the availability of transcription factor binding sites (Pauken et al., 2016; Russ et al., 2014; Scharer et al., 2013; Scott-Browne et al., 2016; Sen et al., 2016; Yu et al., 2017) . Furthermore, because of structural divergences in its IRF domain (Escalante et al., 2002) , IRF8 requires a DNA-binding partner (e.g., Ets, AP-1, or other IRF family members) to bind DNA with high affinity (Tamura et al., 2008) . It is unknown whether IRF8 utilizes the same binding partners in NK cells as it does in other hematopoietic cells, yet the availability or modification of binding partners secondary to different NK cell states could dictate the set of genes regulated by IRF8. Indeed, this mechanism has been described in macrophages wherein the ability of IRF8 to bind alternative DNA sequences after LPS or IFN-g stimulation is dependent on stimulus-inducible partners (Kuwata et al., 2002; Mancino et al., 2015) . Further understanding of the complete molecular mechanisms that regulate IRF8 transcriptional activity will offer valuable insights into how antigen-specific NK cells generate robust proliferative responses to viral infection.
In summary, our work highlights the importance of IRF8 in orchestrating adaptive NK cell antiviral responses. Because proinflammatory cytokines are necessary and sufficient for IRF8 upregulation in NK cells, it will be of interest to test whether IRF8 is similarly induced and required for the function of other innate lymphoid cell lineages, which lack antigen receptors and are thought to initiate antimicrobial responses by sensing cytokines, alarmins, and inflammatory mediators (Sonnenberg and Artis, 2015) . Analogous to expansion of mouse Ly49H + NK cells during MCMV infection, HCMV-seropositive individuals exhibit an expanded and long-lived population of NKG2C + NK cells (Gumá et al., 2004; Hendricks et al., 2014; Lopez-Vergè s et al., 2011) that are capable of recall responses (Foley et al., 2012) . Whether these adaptive NK cell responses in humans similarly require IRF8 during HCMV infection remains to be determined. Nevertheless, our results uncover molecular events that provide insight into the upstream regulation and downstream transcriptional program of IRF8 and shed light on ways to modulate NK cell antiviral immunity for therapeutic benefit.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
All mice used in this study were housed and bred under specific pathogen-free conditions at Memorial Sloan Kettering Cancer Center, and handled in accordance with the guidelines of the Institutional Animal Care and Use Committee (IACUC). The following mouse strains were used in this study: C57BL/6 (CD45.2), B6.SJL (CD45.1), B6 CD45.1xCD45.2, Irf8
, m157-Tg (Tripathy et al., 2008) , Rag2 À/À IL2rg À/À , and Zbtb32 À/À (Hirahara et al., 2008) . Experiments were conducted using age-and gender-matched mice in accordance with approved institutional protocols.
Virus MCMV (Smith strain) was serially passaged through BALB/c hosts three times, and then salivary gland viral stocks were prepared with a dounce homogenizer for dissociating the salivary glands of infected mice 3 weeks after infection. Recombinant VSV-m157 was made by cloning the coding sequence for the MCMV glycoprotein m157 into the parental VSV Indiana strain provided by K. Schluns (MD Anderson) (Firth et al., 2013) .
METHOD DETAILS Mixed Bone Marrow Chimeras
Mixed bone marrow chimeric mice were generated by lethally irradiating (900 cGy) host CD45. 
Continued
In Vivo Virus Infection Adoptive co-transfer studies were performed by transferring splenocytes from WT (CD45.1) and genetic-deficient (CD45.2) mice, mixed to achieve equal numbers of Ly49H + KLRG1 lo NK cells, into Klra8 À/À recipients 1 day prior to MCMV infection. Recipient mice in adoptive co-transfer studies were infected either with MCMV by i.p. injection of 7.5 3 10 2 plaque-forming units (PFU) in 0.5 mL or with VSV-m157 by i.v. injection of 1 3 10 7 PFU in 0.2 mL. Mixed bone marrow chimeric mice and mice in survival experiments received 7.5 3 10 3 PFU or 4 3 10 4 PFU MCMV respectively in 0.5 mL by i.p. injection.
In some experiments, recipient mice were treated for 3 consecutive days with 4 mg/day of tamoxifen (Sigma) dissolved in 0.2 mL corn oil or with 0.2 mL corn oil control (Sigma) by oral gavage, beginning on day 7 after infection.
Hapten Contact Hypersensitivity
To study NK-cell-mediated contact hypersensitivity responses, experimental mice were depleted of circulating T cells with 100 mg anti-CD8a (Bio X Cell, clone 2.43) and 400 mg anti-CD4 (Bio X Cell, clone GK1.5) depletion antibodies 3 days prior to sensitization as well as on the days of sensitization and challenge. Mice were sensitized on consecutive days by treating the shaved abdominal skin with 20 mL of 0.5% 1-fluoro-2,4-dinitrobenzene (DNFB, Sigma) in a 4:1 mixture of acetone (Fisher Scientific) to olive oil (Sigma). Mice were challenged 4 days later by treating both surfaces of the left ear with 10 mL of 0.45% DNFB in a 4:1 acetone to olive oil mixture. Both surfaces of the contralateral ear were treated with 10 mL of a 4:1 acetone to olive oil mixture (vehicle) as a control. Ear thickness was measured using a K€ afer dial thickness gauge (Long Island Indicator Service).
Virus Quantification MCMV viral titers were determined as previously described (Johnson et al., 2016) . DNA was isolated from peripheral blood using the QIAamp DNA Blood Mini Kit (QIAGEN). Following isolation, the DNA concentration was measured using Nanodrop for each sample, and 3 mL was added into a mastermix containing iQ SYBR Green (Bio-Rad) and primers specific to MCMV IE-1 DNA (forward: TCGCCCATCGTTTCGAGA, reverse: TCTCGTAGGTCCACTGACGGA). Copy number was determined by comparing Cq values to a standard curve of known dilutions of an MCMV plasmid and normalizing relative to total DNA content.
Lymphocyte Isolation
Spleens were dissociated using glass slides and filtered through a 100-mm strainer. To isolate lymphocytes from liver, the tissue was physically dissociated using a glass tissue homogenizer and purified using a discontinuous gradient of 40% over 60% Percoll. To isolate cells from the lung, the tissue was physically dissociated using scissors and incubated for 30 min in digest solution (1 mg/mL type D collagenase in RPMI supplemented with 5% fetal calf serum, 1% L-glutamine, 1% penicillin-streptomycin, and 10 mM HEPES). Resulting dissociated tissue was passed through 100-mm strainers, centrifuged, and lymphocytes were removed from the supernatant. To isolate bone marrow lymphocytes, cleaned femur and tibia bones were ground with mortar and pestle, and the resulting solution filtered through a 100-mm strainer. Red blood cells in spleen, liver, lung, and bone marrow were lysed using ACK lysis buffer.
Flow Cytometry and Cell Sorting
Cell surface staining of single-cell suspensions from various organs was performed using fluorophore-conjugated antibodies (BD Biosciences, eBioscience, BioLegend, Tonbo Biosciences, Cell Signaling Technology). Intracellular staining was performed by fixing and permeabilizing with the eBioscience Foxp3 Transcription Factor Staining Set (Thermo Fisher) for staining intranuclear proteins and cytokines, or with formaldehyde and methanol for staining phosphorylated STAT proteins.
Flow cytometry and cell sorting were performed on the LSR II and Aria II cytometers (BD Biosciences), respectively. Data were analyzed with FlowJo software (Tree Star). Flow cytometry of lymphocytes was performed using the following fluorophoreconjugated antibodies: CD3ε (17A2), TCRb (H57-597), CD19 (6D5), F4/80 (BM8.1), NK1.1 (PK136), NKp46 (29A1.4), Ly49H (3D10), CD45.1 (A20), CD45.2 (104), CD45 (30-F11), IRF8 (V3GYWCH), CD11b (M1/70), CD27 (LG.7F9), KLRG1 (2F1), Ly49D (4E5), Ly49A (YE1/48.10.6), Ly49C/I (5E6), STAT4 pY693 (38/p-Stat4), STAT5 pY694 (C11C5), F(ab')2 Rabbit IgG (polyclonal), CD69 (H1.2F3), Granzyme B (GB11), IFN-g (XMG1.2), CD107a (1D4B), CD8a (53-6.7), and Bcl-2 (3F11).
Apoptosis was evaluated by caspase activity staining using the carboxyfluorescein FLICA poly caspase assay kit (Bio-Rad). NK cell proliferation was analyzed by labeling cells with 5 mM CTV (Thermo Fisher) prior to transfer, and CTV labeling was performed according to manufacturer protocol.
Ex Vivo Stimulation of Lymphocytes
Approximately 10 6 spleen lymphocytes were stimulated for 4 hr in RPMI containing 10% fetal bovine serum with 20 ng/mL recombinant mouse IL-12 (R&D Systems) plus 10 ng/mL IL-18 (MBL) or 50 ng/mL PMA (Sigma) plus 500 ng/mL Ionomycin (Sigma). Cells were cultured in media alone as a negative control.
Chromatin Immunoprecipitation and Sequencing 5 3 10 6 to 10 3 10 6 NK cells (TCRb À CD3ε À CD19 À F4/80 À NK1.1 + ) were first enriched from spleens of pooled C57BL/6 mice by negative selection over BioMag goat anti-rat IgG beads (QIAGEN) coated with rat anti-mouse CD8a, CD4, CD19, and Ter-119 antibodies
